John M. Evans, CEO at Beam Therapeutics Inc. (BEAM), sold 91,543 shares at $36.59 ($3.5M) on 2022-04-28, disclosed to the SEC on 2022-05-02.
Open-market sale of $3.5M BEAM by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.59 | 3,900 | $143K | 4.1% |
| 2 | $36.98 | 6,450 | $239K | 6.9% |
| 3 | $36.98 | 6,450 | $239K | 6.9% |
| 4 | $37.48 | 13,655 | $512K | 14.7% |
| 5 | $37.48 | 13,655 | $512K | 14.7% |
| 6 | $37.84 | 7,745 |
| $293K |
| 8.4% |
| 7 | $37.84 | 7,745 | $293K | 8.4% |
| 8 | $38.32 | 6,842 | $262K | 7.5% |
| 9 | $38.32 | 6,842 | $262K | 7.5% |
| 10 | $38.75 | 3,100 | $120K | 3.5% |
| 11 | $39.49 | 4,503 | $178K | 5.1% |
| 12 | $39.49 | 4,503 | $178K | 5.1% |
| 13 | $39.73 | 2,348 | $93K | 2.7% |
| 14 | $39.73 | 2,348 | $93K | 2.7% |
| 15 | $40.73 | 1,100 | $45K | 1.3% |
| 16 | $40.88 | 357 | $15K | 0.4% |
| Total | $37.97 avg | 91,543 | $3.5M | 100% |
| Filing → |
| BEAM | SELL | 2026-04-01 | $1.1M | — | Filing → |
| BEAM | SELL | 2026-02-02 | $2.8M | — | Filing → |
| BEAM | SELL | 2025-10-03 | $1.2M | — | Filing → |